About Teliqon Pharmaceutical
Teliqon Pharmaceutical is a Healthcare company. Pharmaceutical products and services in healthcare sectors in India. The company has 1 employees. Its Indian entity Teliqon Pharmaceutical Private Limited reported revenue of ₹5.2 Lakh. Teliqon Pharmaceutical offers products and services including TELiqon-XT TAB and TELiqon-cv 625 TAB. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Medical Services.
Company details
Teliqon Pharmaceutical is recognized as a leading Indian pharmaceutical company based in New Delhi, where products are offered in therapeutic areas including antibiotics, cough expectorants, proton pump inhibitors, multi-vitamins, multi-minerals, and painkillers. Efforts are made to maintain the highest quality standards in the industry, supported by 354 qualified staff and 128 total products that ensure 100 quality. The company operates with emergency services available 247, and its products are distributed to meet healthcare needs across various sectors.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website teliqonpharma.com
- Legal Name Teliqon Pharmaceutical Private Limited
- Date of Incorporation 18 Jun, 2020
- Jurisdiction Delhi, India
- Indian entity revenue₹5.2 Lakh
FY 2025 · -20% YoY
- Indian entity net profit₹1,461
FY 2025 · 0% margin
- Indian entity EBITDA₹4,251
FY 2025 · 1% margin
- Employee Count1
Associated legal entities of Teliqon Pharmaceutical
Teliqon Pharmaceutical operates through Teliqon Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Teliqon Pharmaceutical Private Limited CIN U51909DL2020PTC364984 | Active | 18 Jun 2020 | Delhi, Delhi | ₹0.1 Cr | 2 | View details |
Products & Services of Teliqon Pharmaceutical
Teliqon Pharmaceutical offers a comprehensive portfolio of products and services, including TELiqon-XT TAB and TELiqon-cv 625 TAB.
This product is utilized in therapeutic areas and is listed among the company's offerings.
This product is provided as part of the range in therapeutic areas such as antibiotics.
Board of directors of Teliqon Pharmaceutical Private Limited (Teliqon Pharmaceutical)
Teliqon Pharmaceutical Private Limited is the primary company behind Teliqon Pharmaceutical. The board of Teliqon Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Ram Nivas Mishra, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ram Nivas Mishra DIN 08766474 | Director | 18 Jun 2020 | 6 yrs 4 mo | Teliqon Pharmaceutical Private Limited |
| Rubi Kumari DIN 08766475 | Director | 18 Jun 2020 | 6 yrs 4 mo | Teliqon Pharmaceutical Private Limited |
Financials of Teliqon Pharmaceutical
Figures of Teliqon Pharmaceutical Private Limited, the primary company behind Teliqon Pharmaceutical, for FY 2025. Revenue was ₹5.2 Lakh (-20% year on year). Net profit was ₹1,461 (0% margin). EBITDA was ₹4,251 (1% margin). Revenue has grown at a compounded annual rate of -24% over three years.
- ₹5.2 LakhRevenue · FY 2025 · -20% YoY
- ₹1,461Net profit · 0% margin
- ₹4,251EBITDA · 1% margin
- ₹5 LakhPaid-up capital
- -24%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Teliqon Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Teliqon Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Teliqon Pharmaceutical
Teliqon Pharmaceutical has 1 employees.
The primary company behind Teliqon Pharmaceutical, Teliqon Pharmaceutical Private Limited, reported revenue of ₹5.2 Lakh for FY 2025, down 20% year on year.
Teliqon Pharmaceutical is recognized as a leading Indian pharmaceutical company based in New Delhi, where products are offered in therapeutic areas including antibiotics, cough expectorants, proton pump inhibitors, multi-vitamins, multi-minerals, and painkillers. Efforts are made to maintain the highest quality standards in the industry, supported by 354 qualified staff and 128 total products that ensure 100 quality. The company operates with emergency services available 247, and its products are distributed to meet healthcare needs across various sectors.
Teliqon Pharmaceutical offers TELiqon-XT TAB and TELiqon-cv 625 TAB.
Teliqon Pharmaceutical operates through Teliqon Pharmaceutical Private Limited.
The legal entities of Teliqon Pharmaceutical currently have 2 directors, including Ram Nivas Mishra, Rubi Kumari.